Pharmaceutical manufacturing of APIs, intermediates, and related chemicals in India.
Annual revenue $60.0M Latest available
Total funding - Funding intelligence
Employees 210 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Raichem

Raichem is a company. The company has 210 employees as of April 06, 2024. Raichem offers products and services including Ursodeoxycholic Acid (UDCA) and Intermediates.

  • Employees 210 as on 06 Apr, 2024
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Raichem Medicare Private Limited
  • Jurisdiction Chicksugur Village, Karnataka, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Chemicals & Materials → Specialty & Industrial Chemicals Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $59.95 M (USD)
    10.91
    as on Mar 31, 2023
  • Net Profit
    $1.25 M (USD)
    -42.58
    as on Mar 31, 2023
  • EBITDA
    $4.85 M (USD)
    4.15
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    210

    as on Apr 06, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Raichem

Raichem offers a comprehensive portfolio of products and services, including Ursodeoxycholic Acid (UDCA) and Intermediates.

Product name locked
Category locked
Primary

Ursodeoxycholic acid is utilized for the treatment of primary biliary cirrhosis and gallstone dissolution in patients with functioning gallbladders.

Product name locked
Category locked
Locked

Intermediates for UDCA production are manufactured and supplied for pharmaceutical applications, supporting the synthesis of bile acid derivatives.

People of Raichem

Headcount 1000-5000
Employee Profiles 15
Board Members and Advisors 6
Employee Profiles
People
K. H. Honneshaiah
Head of Operations, API
People
Vishnukant C. Bhutada
Managing Director
People
Alpesh Dalal
CFO
People
V. Prakash
SVP, Global Business Head, API Business

Unlock access to complete

Board Members and Advisors
people
Sharatha Reddy
Director
people
Arvind Vasudeva
Director
people
Hetal Madhukant Gandhi
Director
people
Kishore Sharma
Director

Unlock access to complete

Funding Insights of Raichem

Premium access

Detailed funding history for Raichem

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Raichem

Investments
Premium access

Investment portfolio details for Raichem

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Raichem

Premium access

Detailed financials for Raichem

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Raichem Comparisons

Raichem Primary company
Description
Pharmaceutical manufacturing of APIs, intermediates, and rel...
Location
-
Founded Year
-
Annual Revenue
$59.95 M (USD)
Net Profit
$1.25 M (USD)
EBITDA
$4.85 M (USD)
Employees
210
As of 2024
Premium access

Peer comparison for Raichem

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Raichem

Premium access

Detailed competitors of Raichem

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Raichem

Premium access

Complete news archive for Raichem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raichem

As of Apr 06, 2024, the latest employee count at Raichem is 210.

Annual revenue of Raichem is $59.95M as on Mar 31, 2023.

Raichem, an ICE Pharma Company, was established in 2009 in India with a focus on producing ursodeoxycholic acid and its intermediates. The facility is situated in Raichur, Karnataka, and has been certified with ISO 50001, ISO 9001, ISO 14001, and ISO 45001 standards. Manufacturing processes are supported by RD activities that emphasize the development of generic APIs and improvements in bile acid chemistry. Corporate social responsibility policies are implemented to ensure environmental care and employee safety, while products are supplied to markets in India and Southeast Asia.

Raichem offers Ursodeoxycholic Acid (UDCA) and Intermediates.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available